DEA schedule
Is risperidone a controlled substance?
Federal schedule for risperidone from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Risperidone is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and risperidone is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted risperidone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 176 prescription listings from 37 labelers, none with a DEA schedule |
| DEA controlled substances list | risperidone is not on the list |
Risperidone NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50458-305 | RISPERDAL | solution | 1 mg/mL | Janssen Pharmaceuticals, Inc. | None |
| 50458-302 | RISPERDAL | tablet | .5 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-300 | RISPERDAL | tablet | 1 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-320 | RISPERDAL | tablet | 2 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-330 | RISPERDAL | tablet | 3 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-350 | RISPERDAL | tablet | 4 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-395 | RISPERDAL M-TAB | tablet, orally disintegrating | .5 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-315 | RISPERDAL M-TAB | tablet, orally disintegrating | 1 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-325 | RISPERDAL M-TAB | tablet, orally disintegrating | 2 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-335 | RISPERDAL M-TAB | tablet, orally disintegrating | 3 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-355 | RISPERDAL M-TAB | tablet, orally disintegrating | 4 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-596 | Risperidone | solution | 1 mg/mL | Janssen Pharmaceuticals, Inc. | None |
| 70518-3760 | Risperidone | solution | 1 mg/mL | REMEDYREPACK INC. | None |
| 51759-520 | UZEDY | injection, suspension, extended release | 100 mg/.28mL | Teva Pharmaceuticals USA, Inc. | None |
| 51759-630 | UZEDY | injection, suspension, extended release | 125 mg/.35mL | Teva Pharmaceuticals USA, Inc. | None |
| 51759-740 | UZEDY | injection, suspension, extended release | 150 mg/.42mL | Teva Pharmaceuticals USA, Inc. | None |
| 51759-850 | UZEDY | injection, suspension, extended release | 200 mg/.56mL | Teva Pharmaceuticals USA, Inc. | None |
| 51759-960 | UZEDY | injection, suspension, extended release | 250 mg/.7mL | Teva Pharmaceuticals USA, Inc. | None |
| 51759-305 | UZEDY | injection, suspension, extended release | 50 mg/.14mL | Teva Pharmaceuticals USA, Inc. | None |
| 51759-410 | UZEDY | injection, suspension, extended release | 75 mg/.21mL | Teva Pharmaceuticals USA, Inc. | None |
| 17856-1002 | Risperidone | solution | 1 mg/mL | ATLANTIC BIOLOGICALS CORP. | None |
| 27808-002 | Risperidone | solution | 1 mg/mL | Cranbury Pharmaceuticals, LLC | None |
| 62135-929 | RISPERIDONE | solution | 1 mg/mL | Chartwell RX, LLC | None |
| 62559-981 | Risperidone | solution | 1 mg/mL | ANI Pharmaceuticals, Inc. | None |
| 65162-673 | Risperidone | solution | 1 mg/mL | Amneal Pharmaceuticals LLC | None |
| 65862-167 | RISPERIDONE | solution | 1 mg/mL | Aurobindo Pharma Limited | None |
| 70518-3741 | Risperidone | solution | 1 mg/mL | REMEDYREPACK INC. | None |
| 71335-2733 | Risperidone | solution | 1 mg/mL | Bryant Ranch Prepack | None |
| 72162-2037 | Risperidone | solution | 1 mg/mL | Bryant Ranch Prepack | None |
| 83745-186 | Risperidone | solution | 1 mg/mL | APOZEAL PHARMACEUTICALS INC | None |
| 0615-8196 | Risperidone | tablet | .25 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 13668-035 | Risperidone | tablet | .25 mg/1 | Torrent Pharmaceuticals Limited | None |
| 27241-002 | RISPERIDONE | tablet | .25 mg/1 | Ajanta Pharma USA Inc. | None |
| 43547-339 | Risperidone | tablet | .25 mg/1 | Solco Healthcare US, LLC | None |
| 59746-221 | Risperidone | tablet | .25 mg/1 | Jubilant Cadista Pharmacuticals Inc. | None |
| 67046-2064 | Risperidone | tablet | .25 mg/1 | Coupler LLC | None |
| 69238-2108 | Risperidone | tablet | .25 mg/1 | Amneal Pharmaceuticals NY LLC | None |
| 70518-1771 | RISPERIDONE | tablet | .25 mg/1 | REMEDYREPACK INC. | None |
| 71205-520 | RISPERIDONE | tablet | .25 mg/1 | Proficient Rx LP | None |
| 71335-0740 | RISPERIDONE | tablet | .25 mg/1 | Bryant Ranch Prepack | None |
Showing 40 of 176 listings.
Questions
Is risperidone a controlled substance?
No. Risperidone is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and risperidone is not on the DEA controlled substances list.
Is risperidone a narcotic?
No. Risperidone is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Atypical Antipsychotic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Risperidone
- What is Risperidone used for?FDA label uses
- Generic for RykindoFDA Orange Book
- Generic for Risperdal ConstaFDA Orange Book
- Generic for RisperdalFDA Orange Book
- Generic for UzedyFDA Orange Book
- What is Uzedy used for?FDA label uses
- Is Uzedy a controlled substance?Federal schedule
- Atypical Antipsychotics listFDA drug class
- NDC 50458-300Risperidone NDC record
- NDC 50458-302Risperidone NDC record
- NDC 50458-305Risperidone NDC record